Clinical Trial Update: Treatment for Patients Suffering From Anemia Due to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epoetin alfa for chemotherapy-induced anemia in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Breast Cancer

Drugs mentioned

• epoetin alfa (Epogen, Procrit) (epoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer, Anemia | Phase 2 | Status: COMPLETED